Nasdaq ubx.

August 16, 2022 16:01 ET | Source: Unity Biotechnology, Inc. SOUTH SAN FRANCISCO, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (Nasdaq:UBX), a biotechnology ...Home UBX • NASDAQ. Unity Biotechnology Inc. Follow. Share. $1.92. After Hours: $1.91. (0.52%) -0.0100. Closed: Dec 1, 7:36:27 PM GMT-5 · USD · NASDAQ · Disclaimer. Nov 24, 2023 · UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds. SOUTH SAN FRANCISCO, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY” or the “Company”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or rev... 15 days ago - GlobeNewsWire. Unity Biotechnology (NASDAQ: UBX) primarily focuses on developing therapeutics targeting age-related ophthalmologic and neurologic diseases. Its main candidate, UBX1325, is being studied for ...

Unity Biotechnology, Inc. (NASDAQ: UBX) was in 4 hedge funds’ portfolios at the end of the first quarter of 2021. The all time high for this statistic is 7. UBX shareholders have witnessed a ...TARGETING A ROOT CAUSE. Age-related diseases, such as vision loss and cognitive decline, cause considerable economic, personal, and societal burden for individuals, their families, and broader communities. By targeting age-related diseases, we believe that UNITY can treat these diseases, as well as contain healthcare costs and lessen the ...

SOUTH SAN FRANCISCO, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...SOUTH SAN FRANCISCO, Calif., Sept. 19, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...

Nov 1, 2022 · November 1, at 8:00 a.m. ET. SOUTH SAN FRANCISCO, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology company developing therapeutics ... Home UBX • NASDAQ. Unity Biotechnology Inc. Follow. Share. $1.92. After Hours: $1.91. (0.52%) -0.0100. Closed: Dec 1, 7:36:27 PM GMT-5 · USD · NASDAQ · Disclaimer. Find the latest Institutional Holdings data for Unity Biotechnology, Inc. Common Stock (UBX) at Nasdaq.com.Oct 17, 2023 · Unity Biotechnology (NASDAQ: UBX) primarily focuses on developing therapeutics targeting age-related ophthalmologic and neurologic diseases. Its main candidate, UBX1325, is being studied for ... Overview Stock Screener Earnings Calendar Sectors Nasdaq | UBX U.S.: Nasdaq Unity Biotechnology Inc. Watch list NEW Set a price target alert After Hours Last Updated: Oct …

SOUTH SAN FRANCISCO, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...

Follow. SOUTH SAN FRANCISCO, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or ...

SOUTH SAN FRANCISCO, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of ...Find the latest Earnings Report Date for Unity Biotechnology, Inc. Common Stock (UBX) at Nasdaq.com.SOUTH SAN FRANCISCO, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...Nov 18, 2023 · Unity Biotechnology Inc (NASDAQ:UBX) trade information. Upright in the green during last session for gaining 17.68%, in the last five days UBX remained trading in the green while hitting it’s week-highest on Friday, 11/17/23 when the stock touched $2.13 price level, adding 1.39% to its value on the day. The reverse stock split will become effective at 5:00 PM Eastern Time today, October 19, 2022, after close of trading on the Nasdaq Global Select Market. UNITY’s common stock is expected to ...SOUTH SAN FRANCISCO, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing ...SOUTH SAN FRANCISCO, Calif., Jan. 18, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...

SAN FRANCISCO, May 26, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging ...Unity Biotechnology (NASDAQ: UBX) primarily focuses on developing therapeutics targeting age-related ophthalmologic and neurologic diseases. Its main candidate, UBX1325, is being studied for ...Based on analysts offering 12 month price targets for UBX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . UBX Latest Real Time Trades · Trending Stocks · Your symbols have been updated · Edit Watchlist · Opt in to Smart Portfolio · Privacy Preference Center. When ...1. GCI / Gannett Co Inc. Mass media holding company Gannett Co holds the top spot on the gamma squeeze leaderboard with a score of 97.78. Short interest only equates to 5.64% of the float, however ...Unity Biotechnology (UBX) Insider Trading Activity 2023. MarketBeat Week in Review – 11/27 - 12/1. Teen girls are being victimized by deepfake nudes. One family is pushing for more protections. S&P 500 4,594.63. DOW 36,245.50.

SOUTH SAN FRANCISCO, Calif., Aug. 12, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...Nov 29, 2023 · See the latest Unity Biotechnology Inc stock price (UBX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

UBX Latest Real Time Trades · Trending Stocks · Your symbols have been updated · Edit Watchlist · Opt in to Smart Portfolio · Privacy Preference Center. When ...November 1, at 8:00 a.m. ET. SOUTH SAN FRANCISCO, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology company developing therapeutics ...SOUTH SAN FRANCISCO, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse ...Unity Biotechnology, Inc. (NASDAQ:UBX) shareholders should be happy to see the share price up 23% in the last month. But only the myopic could ignore the astounding decline over three years.SOUTH SAN FRANCISCO, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse ...SAN FRANCISCO, Oct. 31, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today ...Shares of Unity Biotechnology ( UBX -1.94%) fell over 63% today after the company announced disappointing results from a clinical trial involving its lead drug candidate, UBX0101. At the 12-week ...

Oct 19, 2022 · Follow. SOUTH SAN FRANCISCO, Calif., Oct. 19, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY” or the “Company”) (Nasdaq:UBX), a biotechnology company developing therapeutics to ...

Find the latest Institutional Holdings data for Unity Biotechnology, Inc. Common Stock (UBX) at Nasdaq.com.

(NASDAQ: UBX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.13%. What is UBX's Price Target? According to 4 Wall Street analyst s that have issued a 1 year UBX price target, the average UBX price target is $7.00 , with the highest UBX stock price forecast at $10.00 and the lowest UBX stock price ... Apr 25, 2023 · Unity Biotechnology (NASDAQ:UBX) has observed the following analyst ratings within the last quarter: These 8 analysts have an average price target of $10.5 versus the current price of Unity ... SAN FRANCISCO, March 31, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or ...SAN FRANCISCO, Jan. 22, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or ...SOUTH SAN FRANCISCO, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse ...Shares of Unity Biotechnology ( UBX -1.94%) fell over 63% today after the company announced disappointing results from a clinical trial involving its lead drug candidate, UBX0101. At the 12-week ...The average one-year price target for Unity Biotechnology (NASDAQ:UBX) has been revised to 6.63 / share. This is an increase of 8.33% from the prior estimate of 6.12 dated October 31, 2023. SOUTH SAN FRANCISCO, Calif. , Aug. 08, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the second quarter ended June 30, 2023 . June 21, 2023. UNITY Announces Design of …Aug 10, 2021 · A look at the shareholders of Unity Biotechnology, Inc. (NASDAQ:UBX) can tell us which group is most powerful. Insiders often own a large chunk of younger, smaller, companies while huge companies ... Overview Stock Screener Earnings Calendar Sectors Nasdaq | UBX U.S.: Nasdaq Unity Biotechnology Inc. Watch list NEW Set a price target alert After Hours Last Updated: Oct 27, 2023 7:54 p.m....SOUTH SAN FRANCISCO, Calif., Aug. 16, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of ...SAN FRANCISCO, Nov. 06, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or ...

SAN FRANCISCO, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting ...SOUTH SAN FRANCISCO, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (Nasdaq:UBX), a biotechnology company developing therapeutics to slow, halt, or reverse ...UBX ( NASDAQ BIOTECH PENNY) crushes earnings and news catalyst NASDAQ:UBX and rises over 100 % in premarket, Has a new product for macular degeneration, a widespread medical problem affecting vision in the elderly which is increasing in incidence. The earning beat was significant. 16-week results from Phase 2 study in wet AMD expected in Q4 2022. SOUTH SAN FRANCISCO, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a ...Instagram:https://instagram. budwesier stockamryisretirement planning apphow to buy vix call options SOUTH SAN FRANCISCO, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases ...SAN FRANCISCO, Dec. 03, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or ... 5 stocks under 5mbio stock forecast Domo Inc. (NASDAQ:DOMO) is the most popular stock in this table. On the other hand Unity Biotechnology, Inc. (NASDAQ:UBX) is the least popular one with only 5 bullish hedge fund positions ... pnov Unity Biotechnology, Inc. (NASDAQ:UBX – Free Report) – Equities researchers at Wedbush upped their FY2023 earnings per share estimates for shares of Unity Biotechnology in a research report issued to clients and investors on Thursday, November 16th. Wedbush analyst A. Argyrides now anticipates that the company will post earnings per share of ($2.66) for the […]Wedbush analyst Andreas Argyrides upgraded the shares of Unity Biotechnology Inc (NASDAQ: UBX) from Neutral to Outperform and raised the price target from $2 to $4. Unity Biotechnology is ...